[Congressional Record Volume 164, Number 97 (Tuesday, June 12, 2018)]
[Senate]
[Page S3847]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2819. Mr. UDALL (for himself, Mrs. Shaheen, Mr. Portman, Mr. 
Brown, and Mr. Manchin) submitted an amendment intended to be proposed 
to amendment SA 2282 proposed by Mr. Inhofe (for himself and Mr. 
McCain) to the bill H.R. 5515, to authorize appropriations for fiscal 
year 2019 for military activities of the Department of Defense, for 
military construction, and for defense activities of the Department of 
Energy, to prescribe military personnel strengths for such fiscal year, 
and for other purposes; which was ordered to lie on the table; as 
follows:

       At the end of subtitle F of title X, add the following:

     SEC. 1066. PUBLICATION OF TOXICOLOGICAL PROFILE FOR CERTAIN 
                   PER- AND POLYFLUOROALKYL SUBSTANCES.

       (a) In General.--Not later than seven days after the date 
     of the enactment of this Act, the Secretary of Health and 
     Human Services shall publish in the Federal Register and on 
     an Internet website of the Department of Health and Human 
     Services the results of the toxicological profile prepared by 
     the Agency for Toxic Substances and Disease Registry of the 
     Department pursuant to section 104(i)(2) of the Comprehensive 
     Environmental Response, Compensation, and Liability Act of 
     1980 (42 U.S.C. 9604(i)(2)) regarding the health effects of 
     exposure to the following per- and polyfluoroalkyl 
     substances:
       (1) Perfluorooctanoic acid.
       (2) Perfluorooctane sulfonic acid.
       (3) Perfluorononanoic acid.
       (4) Perfluorohexane sulfonic acid.
       (b) Report.--Not later than seven days after the date of 
     the enactment of this Act, the Secretary of Health and Human 
     Services shall submit to Congress a report identifying any 
     changes made after January 30, 2018, to the toxicology 
     profiles of per- and polyfluoroalkyl substances specified in 
     subsection (a).
                                 ______